共 8 条
[1]
U tility of a lung b iopsy for the d iagnosis of id iopath ic pu lm onaryfibrosis. Hunn inghake G W,Z imm erm an M B,Schw artz D A,et a l. Am J R esp ir C rit C are M ed . 2001
[2]
Pharm aco log ica l therapy for id iopath ic pu lm onary fibrosis. M ason R J,Schw arz M I,Hunn inghake G W,et a l. Am J R esp ir C rit C are M ed . 1999
[3]
Id iopath ic pu lm onary fibrosis:d iagnosis andtreatm en t in ternationa l consensus statem en t. ATS/ERS. Am J R esp irC rit C are M ed . 2000
[4]
A prelim inary studyof long-term treatm en t w ith IFN-γ1b and low-dose predn iso lonein patien ts w ith id iopath ic pu lm onary fibrosis. Z iesche R,Hofbaur E,W ittm ann K,et a l. N ew Eng JMed . 1999
[5]
C ryptogen ic fibrosing a lveo litis. Chan-Y eung M,M u ller N L. The Lancet . 1997
[6]
Am erican Thoracic Society/European R esp iratorySociety in ternationa lm u ltid iscip linary consensus classification ofthe id iopath ic in terstitia l pneum on ias. ATS/ERS. Am J R esp ir C rit C areM ed . 2002
[7]
In terstitia l lung d iseases:A d iagnostic approach:A reCT scan and lung b iopsy ind icated in every patien t. R aghu G. Am JR esp ir C rit C are M ed . 1995
[8]
A na lyses of efficacy endpo in ts in a con tro lled tria l of in terferon-gamm a1b for id iopath icpu lm onary fibrosis. K ing T E Jr,Safrin S,S tarko K M. Chest . 2005